95 employees
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
2016
$100M
from 2 investors over 2 rounds
Madrigal Pharmaceuticals raised $100M on May 9, 2022
Investors: Hercules Capital, Inc.
Madrigal Pharmaceuticals raised undisclosed on April 1, 2014
Investors: Bay City Capital